Page last updated: 2024-10-21

phaclofen and Brain Neoplasms

phaclofen has been researched along with Brain Neoplasms in 1 studies

phaclofen: peripheral & central baclofen & GABA antagonist; structure given in first source

Brain Neoplasms: Neoplasms of the intracranial components of the central nervous system, including the cerebral hemispheres, basal ganglia, hypothalamus, thalamus, brain stem, and cerebellum. Brain neoplasms are subdivided into primary (originating from brain tissue) and secondary (i.e., metastatic) forms. Primary neoplasms are subdivided into benign and malignant forms. In general, brain tumors may also be classified by age of onset, histologic type, or presenting location in the brain.

Research Excerpts

ExcerptRelevanceReference
"Phaclofen was about 700-fold less potent than CGP 52432 (IC50 = 70."1.29Characterization of the GABA autoreceptor in human neocortex as a pharmacological subtype of the GABAB receptor. ( Bonanno, G; Cavazzani, P; Fassio, A; Raiteri, M, 1994)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Fassio, A1
Bonanno, G1
Cavazzani, P1
Raiteri, M1

Other Studies

1 other study available for phaclofen and Brain Neoplasms

ArticleYear
Characterization of the GABA autoreceptor in human neocortex as a pharmacological subtype of the GABAB receptor.
    European journal of pharmacology, 1994, Oct-03, Volume: 263, Issue:3

    Topics: Adolescent; Adult; Aged; Animals; Baclofen; Benzylamines; Binding, Competitive; Brain Neoplasms; Cer

1994